IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
2.000
-0.100 (-4.76%)
At close: Sep 15, 2025, 4:00 PM EDT
2.029
+0.029 (1.47%)
After-hours: Sep 15, 2025, 6:20 PM EDT

IN8bio Statistics

Total Valuation

IN8bio has a market cap or net worth of $9.08 million. The enterprise value is -$1.07 million.

Market Cap9.08M
Enterprise Value -1.07M

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025, after market close.

Earnings Date Nov 11, 2025
Ex-Dividend Date n/a

Share Statistics

IN8bio has 4.54 million shares outstanding. The number of shares has increased by 93.52% in one year.

Current Share Class 4.54M
Shares Outstanding 4.54M
Shares Change (YoY) +93.52%
Shares Change (QoQ) +48.03%
Owned by Insiders (%) 6.06%
Owned by Institutions (%) 19.43%
Float 4.18M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.56
P/TBV Ratio 0.59
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.03, with a Debt / Equity ratio of 0.20.

Current Ratio 7.03
Quick Ratio 6.77
Debt / Equity 0.20
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -165.56% and return on invested capital (ROIC) is -76.32%.

Return on Equity (ROE) -165.56%
Return on Assets (ROA) -69.05%
Return on Invested Capital (ROIC) -76.32%
Return on Capital Employed (ROCE) -132.78%
Revenue Per Employee n/a
Profits Per Employee -$1.33M
Employee Count18
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -78.94% in the last 52 weeks. The beta is 0.02, so IN8bio's price volatility has been lower than the market average.

Beta (5Y) 0.02
52-Week Price Change -78.94%
50-Day Moving Average 2.23
200-Day Moving Average 5.32
Relative Strength Index (RSI) 38.91
Average Volume (20 Days) 50,279

Short Selling Information

The latest short interest is 45,893, so 1.01% of the outstanding shares have been sold short.

Short Interest 45,893
Short Previous Month 71,412
Short % of Shares Out 1.01%
Short % of Float 1.10%
Short Ratio (days to cover) 0.59

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -23.13M
Pretax Income -31.96M
Net Income -23.89M
EBITDA -21.12M
EBIT -23.13M
Earnings Per Share (EPS) -$9.54
Full Income Statement

Balance Sheet

The company has $13.23 million in cash and $3.12 million in debt, giving a net cash position of $10.11 million or $2.23 per share.

Cash & Cash Equivalents 13.23M
Total Debt 3.12M
Net Cash 10.11M
Net Cash Per Share $2.23
Equity (Book Value) 15.24M
Book Value Per Share 3.74
Working Capital 11.79M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$17.19 million and capital expenditures -$33,000, giving a free cash flow of -$17.22 million.

Operating Cash Flow -17.19M
Capital Expenditures -33,000
Free Cash Flow -17.22M
FCF Per Share -$3.79
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

IN8bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -93.52%
Shareholder Yield -93.52%
Earnings Yield -264.44%
FCF Yield -190.62%

Analyst Forecast

The average price target for IN8bio is $108.00, which is 5,300.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target $108.00
Price Target Difference 5,300.00%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on June 6, 2025. It was a reverse split with a ratio of 1:30.

Last Split Date Jun 6, 2025
Split Type Reverse
Split Ratio 1:30

Scores

Altman Z-Score n/a
Piotroski F-Score 2